Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical hemocoagulase atrox for stress ulcer-related upper gastrointestinal bleeding
ChiCTR2100050584Phase 3Completed
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Jan 2016
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of batroxobin in stress ulcer and upper gastrointestinal bleeding (UGIB) (3 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoints: Vital signs, Risk factor assessment and 2 more. Started Jan 2016; status: completed.
02
Drugs
batroxobin
03
Conditions
stress ulcerupper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on ChiCTR2100050584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050584.